(Q71398733)
Statements
Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma (English)
S Wadler
B Gleissner
R U Hilgenfeld
E Thiel
H Haynes
R Kaleya
A Rozenblit